NYSE:MED Medifast (MED) Stock Price, News & Analysis → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free MED Stock Alerts $35.85 -0.76 (-2.08%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$34.91▼$36.9950-Day Range$34.59▼$64.3752-Week Range$34.09▼$109.52Volume422,194 shsAverage Volume387,328 shsMarket Capitalization$390.77 millionP/E Ratio3.94Dividend YieldN/APrice Target$61.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Medifast alerts: Email Address Medifast MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside70.2% Upside$61.00 Price TargetShort InterestBearish18.22% of Float Sold ShortDividend StrengthN/ASustainability-4.17Upright™ Environmental ScoreNews Sentiment0.12Based on 12 Articles This WeekInsider TradingSelling Shares$159,850 Sold Last QuarterProj. Earnings Growth28.96%From $4.80 to $6.19 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.27 out of 5 starsConsumer Staples Sector34th out of 139 stocksMiscellaneous Food Preparations & Kindred Products Industry1st out of 4 stocks 3.0 Analyst's Opinion Consensus RatingMedifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $61.00, Medifast has a forecasted upside of 70.2% from its current price of $35.85.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted18.22% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Medifast has recently increased by 2.65%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldMedifast does not currently pay a dividend.Dividend GrowthMedifast has only been increasing its dividend for 1 years.Dividend SustainabilityBased on EPS estimates, Medifast will have a dividend payout ratio of 106.62% in the coming year. This indicates that Medifast may not be able to sustain their current dividend. Previous Next 1.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedifast has received a -5.63% net impact score from Upright. The largest negative impact of Medifast in category "GHG emissions" seems to be driven mostly by its "Meal replacement soups", "Meal replacement bars", "Meal replacement drinks", and "Protein bars" products. See details.Environmental SustainabilityThe Environmental Impact score for Medifast is -4.17. Previous Next 2.8 News and Social Media Coverage News SentimentMedifast has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Medifast this week, compared to 4 articles on an average week.Search Interest33 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 32% compared to the previous 30 days.MarketBeat Follows14 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is an increase of 56% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $159,850.00 in company stock.Percentage Held by InsidersOnly 2.06% of the stock of Medifast is held by insiders.Percentage Held by Institutions87.83% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Medifast are expected to grow by 28.96% in the coming year, from $4.80 to $6.19 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 3.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.04.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 3.94, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 22.11.Price to Book Value per Share RatioMedifast has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy About Medifast Stock (NYSE:MED)Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.Read More MED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MED Stock News HeadlinesMarch 12, 2024 | insidertrades.comInsider Selling: Medifast, Inc. (NYSE:MED) Director Sells 4,053 Shares of StockMarch 16, 2024 | finance.yahoo.comMED Apr 2024 20.000 putMarch 18, 2024 | Paradigm Press (Ad)8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: March 14, 2024 | finance.yahoo.comShould You Think About Buying Medifast, Inc. (NYSE:MED) Now?March 14, 2024 | seekingalpha.comLifeMD: Results And Guidance Point To Continued Strength In Weight Management ProgramMarch 13, 2024 | markets.businessinsider.comRobust Growth and Strategic Partnerships Reinforce Buy Rating for LifeMDMarch 12, 2024 | gurufocus.comDirector Scott Schlackman Sells Shares of Medifast Inc (MED)March 12, 2024 | msn.comLifeMD, Inc. (NASDAQ:LFMD) Q4 2023 Earnings Call TranscriptMarch 18, 2024 | Banyan Hill Publishing (Ad)AI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… March 12, 2024 | finanznachrichten.deLifeMD, Inc.: LifeMD Reports Fourth Quarter 2023 ResultsMarch 11, 2024 | americanbankingnews.comMedifast, Inc. to Post FY2024 Earnings of $6.86 Per Share, Zacks Research Forecasts (NYSE:MED)March 8, 2024 | finance.yahoo.comMED Jun 2024 52.500 callMarch 7, 2024 | investorplace.comHey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term GainsMarch 7, 2024 | seekingalpha.comMedifast Is Getting AttractiveMarch 7, 2024 | finance.yahoo.comMED Apr 2024 27.500 putMarch 7, 2024 | finance.yahoo.comMED Nov 2024 52.500 putMarch 1, 2024 | 247wallst.comWant $10,000 in Passive Income? Invest $2,000 in Each of These Dividend StocksFebruary 28, 2024 | 247wallst.comDon't Get Near These 10%+ Dividend Yield StocksFebruary 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Consumer Cyclical Companies: CarGurus (CARG), Lowe’s (LOW) and Medifast (MED)February 23, 2024 | finance.yahoo.comAnalysts Are More Bearish On Medifast, Inc. (NYSE:MED) Than They Used To BeFebruary 22, 2024 | bizjournals.comBaltimore public company sees revenue drop 32.9% in a yearFebruary 22, 2024 | finance.yahoo.comMedifast Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 21, 2024 | marketwatch.comMedifast Shares Drop 16% After Lower 4Q EarningsFebruary 21, 2024 | finance.yahoo.comMedifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/YFebruary 21, 2024 | finance.yahoo.comQ4 2023 Medifast Inc Earnings CallFebruary 21, 2024 | finance.yahoo.comMedifast, Inc. (NYSE:MED) Q4 2023 Earnings Call TranscriptFebruary 20, 2024 | benzinga.comRecap: Medifast Q4 EarningsSee More Headlines Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2024Today3/18/2024Next Earnings (Estimated)5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products Current SymbolNYSE:MED CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees634Year FoundedN/APrice Target and Rating Average Stock Price Target$61.00 High Stock Price Target$82.00 Low Stock Price Target$40.00 Potential Upside/Downside+67.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$9.11 Trailing P/E Ratio4.00 Forward P/E Ratio7.59 P/E GrowthN/ANet Income$99.42 million Net Margins9.27% Pretax Margin12.01% Return on Equity56.06% Return on Assets33.14% Debt Debt-to-Equity RatioN/A Current Ratio2.43 Quick Ratio1.84 Sales & Book Value Annual Sales$1.07 billion Price / Sales0.37 Cash Flow$11.42 per share Price / Cash Flow3.19 Book Value$18.50 per share Price / Book1.97Miscellaneous Outstanding Shares10,900,000Free Float10,672,000Market Cap$397.20 million OptionableOptionable Beta1.15 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Daniel R. Chard (Age 59)Executive Chairman & CEO Comp: $1.94MMr. James P. Maloney CPA (Age 56)Chief Financial Officer Comp: $823.91kMr. Anthony E. Tyree (Age 59)Chief Business Operations Officer Comp: $655.86kMr. Jason L. Groves Esq. (Age 53)Executive VP, General Counsel & Corporate Secretary Comp: $669.51kMr. Nicholas M. Johnson (Age 44)Chief Field Operations Officer Comp: $696.4kMr. Jonathan Barrett MacKenzie (Age 52)VP of Finance & Chief Accounting Officer Mr. Steven ZenkerVice President of Investor RelationsMs. Claudia C. Greninger (Age 51)Chief Human Resources Officer More ExecutivesKey CompetitorsCarriage ServicesNYSE:CSVSeneca FoodsNASDAQ:SENEALimoneiraNASDAQ:LMNRCresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y AgropecuariaNASDAQ:CRESYTurning Point BrandsNYSE:TPBView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 113,734 shares on 3/11/2024Ownership: 15.477%Scott SchlackmanSold 4,053 sharesTotal: $159,850.32 ($39.44/share)Goldman Sachs Group Inc.Bought 15,713 shares on 3/1/2024Ownership: 0.345%Scarborough Advisors LLCBought 11,642 shares on 2/22/2024Ownership: 0.107%Optimist Retirement Group LLCBought 19,959 shares on 2/16/2024Ownership: 0.183%View All Insider TransactionsView All Institutional Transactions MED Stock Analysis - Frequently Asked Questions Should I buy or sell Medifast stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MED, but not buy additional shares or sell existing shares. View MED analyst ratings or view top-rated stocks. What is Medifast's stock price target for 2024? 2 brokers have issued twelve-month price objectives for Medifast's shares. Their MED share price targets range from $40.00 to $82.00. On average, they predict the company's stock price to reach $61.00 in the next twelve months. This suggests a possible upside of 70.2% from the stock's current price. View analysts price targets for MED or view top-rated stocks among Wall Street analysts. How have MED shares performed in 2024? Medifast's stock was trading at $67.22 at the beginning of 2024. Since then, MED shares have decreased by 46.7% and is now trading at $35.85. View the best growth stocks for 2024 here. When is Medifast's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our MED earnings forecast. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) announced its quarterly earnings results on Tuesday, February, 20th. The specialty retailer reported $1.09 EPS for the quarter, beating the consensus estimate of $0.99 by $0.10. The specialty retailer earned $191.02 million during the quarter, compared to the consensus estimate of $184.17 million. Medifast had a net margin of 9.27% and a trailing twelve-month return on equity of 56.06%. The company's revenue for the quarter was down 43.4% compared to the same quarter last year. During the same period last year, the business earned $3.70 EPS. How often does Medifast pay dividends? What is the dividend yield for Medifast? Medifast declared a quarterly dividend on Thursday, September 7th. Shareholders of record on Tuesday, September 19th will be given a dividend of $1.65 per share on Tuesday, November 7th. This represents a $6.60 annualized dividend and a yield of 18.41%. The ex-dividend date is Monday, September 18th. Read our dividend analysis for MED. What ETFs hold Medifast's stock? ETFs with the largest weight of Medifast (NYSE:MED) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), First Trust SMID Cap Rising Dividend Archievers ETF (SDVY), Roundhill Acquirers Deep Value ETF (DEEP), Pacer US Small Cap Cash Cows 100 ETF (CALF), Invesco S&P SmallCap Quality ETF (XSHQ), WisdomTree U.S. SmallCap Quality Dividend Growth Fund (DGRS), Royce Quant Small-Cap Quality Value ETF (SQLV) and Global X Health & Wellness ETF (BFIT). What guidance has Medifast issued on next quarter's earnings? Medifast issued an update on its first quarter 2024 earnings guidance on Tuesday, February, 20th. The company provided earnings per share (EPS) guidance of 0.250-0.950 for the period, compared to the consensus estimate of 1.490. The company issued revenue guidance of $155.0 million-$175.0 million, compared to the consensus revenue estimate of $205.8 million. What is Daniel Chard's approval rating as Medifast's CEO? 44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM). Who are Medifast's major shareholders? Medifast's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (15.49%), Vanguard Group Inc. (15.48%), Pacer Advisors Inc. (4.80%), First Trust Advisors LP (3.65%), Dimensional Fund Advisors LP (2.85%) and Charles Schwab Investment Management Inc. (1.71%). Insiders that own company stock include Andrea B Thomas, Constance J Hallquist, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Jeffrey J Brown, Kevin G Byrnes and Scott Schlackman. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:MED) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.